In anticipation of the start of its 2026-2027 public meeting cycle next month, the Medicare Payment Advisory Commission has published a summary of its anticipated analytic agenda for that period. The major components of that agenda are:
recent trends in Medicare Part D (prescription drug) spending- the processes and information involved in beneficiary enrollment in Medicare
- the effect of Medicare’s quality measurement and value-based purchasing programs on quality and value
- the adequacy of Medicare fee-for-service payments and payment recommendations for the upcoming year
- further analysis of the Medicare Advantage program
Learn more from this MedPAC message to its constituents.